Synjardy XR 25 mg/1

Synjardy XR 25 mg/1 is an extended-release tablet combining empagliflozin and metformin hydrochloride. It is designed to support blood sugar management in adults with type 2 diabetes. This medication is taken orally and is available in a 30-tablet bottle.

Synjardy XR 25 mg/1 is primarily used to help manage blood sugar levels in adults with type 2 diabetes. The combination of empagliflozin and metformin hydrochloride works to improve glycemic control. This medication is often prescribed as part of a comprehensive treatment plan that includes diet and exercise. People often ask, 'What is Synjardy XR used for?' and the answer is that it is designed to assist in maintaining stable blood sugar levels.

Common effects of Synjardy XR 25 mg/1 may include gastrointestinal discomfort, such as nausea or diarrhea, especially when first starting the medication. Some users may also experience urinary tract infections or low blood sugar levels. These effects can vary from person to person and may subside over time as the body adjusts to the medication.

Synjardy XR 25 mg/1 should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication should be stored at room temperature and kept out of reach of children. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Synjardy XR 25 mg/1 may interact with certain medications, including those that affect kidney function or blood sugar levels. It is important to discuss all current medications with a healthcare provider before starting Synjardy XR. Alcohol consumption should be limited, as it can increase the risk of low blood sugar levels. Additionally, certain dietary supplements and over-the-counter medications may also interact with Synjardy XR.